Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1877 to 1926 of 8289 in total 
Value Type: Measured
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
939\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
mannose-6-phosphate isomerase (ec 5.3.1.8) (phosphomannose isomerase) (pmi) (phosphohexomutase). [source:swissprot;acc:p34949]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8454.45\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8783.33\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0389\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nucleobindin 2 precursor (dna-binding protein nefa). [source:swissprot;acc:p80303]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5859.25\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6432.03\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09776\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
940\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
adenosylhomocysteinase (ec 3.3.1.1) (s-adenosyl-l-homocysteine hydrolase) (adohcyase). [source:swissprot;acc:p23526]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5568.96\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6113.35\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09775\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nocturnin (ccr4 protein homolog). [source:swissprot;acc:q9uk39]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7569.42\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7863.85\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0389\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
941\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
caax prenyl protease 1 homolog (ec 3.4.24.-) (prenyl protein-specific endoprotease 1) (farnesylated-proteins converting enzyme 1) (face-1) (zinc metalloproteinase ste24 homolog). [source:swissprot;acc:o75844]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4970.21\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5455.34\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09761\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor ap-2 alpha (ap2-alpha) (activating enhancer- binding protein 2 alpha) (ap-2 transcription factor) (activator protein-2) (ap-2). [source:swissprot;acc:p05549]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8020.09\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8332.09\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.0389\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
942\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
mln 64 protein (star-related lipid transfer protein 3) (stard3) (start domain-containing protein 3) (cab1 protein). [source:swissprot;acc:q14849]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8454.45\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8783.33\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
phosphoglycerate kinase, testis specific (ec 2.7.2.3). [source:swissprot;acc:p07205]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6597.56\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7240.64\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09747\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
943\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
gamma enolase (ec 4.2.1.11) (2-phospho-d-glycerate hydro-lyase) (neural enolase) (nse) (enolase 2). [source:swissprot;acc:p09104]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6597.98\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7241\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09746\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor ap-2 gamma (ap2-gamma) (activating enhancer- binding protein 2 gamma) (transcription factor erf-1). [source:swissprot;acc:q92754]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8020.09\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8332.09\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0389\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
944\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta enolase (ec 4.2.1.11) (2-phospho-d-glycerate hydro-lyase) (skeletal muscle enolase) (mse) (enolase 3). [source:swissprot;acc:p13929]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6597.98\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7241\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09746\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protocadherin fat 2 precursor (hfat2) (multiple epidermal growth factor-like domains 1). [source:swissprot;acc:q9nyq8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8454.45\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8783.33\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0389\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
945\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
alpha enolase (ec 4.2.1.11) (2-phospho-d-glycerate hydro-lyase) (non- neural enolase) (nne) (enolase 1) (phosphopyruvate hydratase). [source:swissprot;acc:p06733]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6597.98\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7241\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09746\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
cadherin-related tumor suppressor homolog precursor (fat protein homolog). [source:swissprot;acc:q14517]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
8454.45\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
8783.33\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.0389\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
946\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
mln64 n-terminal domain homolog (stard3 n-terminal like protein). [source:swissprot;acc:o95772]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
phosphoglycerate kinase 1 (ec 2.7.2.3) (primer recognition protein 2) (prp 2). [source:swissprot;acc:p00558]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6598.37\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7241.32\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09744\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
947\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
signal transducing adaptor molecule 1; signal transducing adaptor molecule. [source:refseq;acc:nm\_003473]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
11797.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10750.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09738\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor ap-2 beta (ap2-beta) (activating enhancer-binding protein 2 beta). [source:swissprot;acc:q92481]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8020.09\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8332.09\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0389\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
948\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
caspase-7 precursor (ec 3.4.22.-) (ice-like apoptotic protease 3) (ice-lap3) (apoptotic protease mch-3) (cmh-1). [source:swissprot;acc:p55210]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4633.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5084.24\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09728\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
dna mismatch repair protein mlh3 (mutl protein homolog 3). [source:swissprot;acc:q9uhc1]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8047.55\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8360.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03889\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
949\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
apopain precursor (ec 3.4.22.-) (cysteine protease cpp32) (yama protein) (cpp-32) (caspase-3) (casp-3) (srebp cleavage activity 1) (sca-1). [source:swissprot;acc:p42574]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4633.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5084.24\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09728\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
cullin homolog 1 (cul-1). [source:swissprot;acc:q13616]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7884.08\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8190.64\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03888\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
950\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
adp-ribosylation factor-like protein 7 (adp-ribosylation factor-like protein lak). [source:swissprot;acc:p56559]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8212.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8531.84\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03885\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
bystin. [source:swissprot;acc:q13895]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
4280.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4697.02\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09718\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
951\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dimethylaniline monooxygenase [n-oxide forming] 5 (ec 1.14.13.8) (hepatic flavin-containing monooxygenase 5) (fmo 5) (dimethylaniline oxidase 5). [source:swissprot;acc:p49326]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5364.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5885.48\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09716\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit d (ec 3.6.3.14) (v-atpase d subunit) (vacuolar proton pump d subunit) (v-atpase ac39 subunit) (v-atpase 40 kda accessory protein) (p39) (32 kda accessory protein). [source:swissprot;acc:p12953]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8212.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8531.84\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.03885\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
952\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ptpl1-associated rhogap 1. [source:refseq;acc:nm\_004815]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8628.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8963.68\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
putative dimethylaniline monooxygenase [n-oxide forming] 6 (ec 1.14.13.8) (flavin-containing monooxygenase 6) (fmo 6) (dimethylaniline oxidase 6). [source:swissprot;acc:o60774]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5364.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5885.48\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09716\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
953\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
casein kinase i alpha s-like. [source:refseq;acc:nm\_145203]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
4906.33\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5382.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09705\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
glyoxylate reductase/hydroxypyruvate reductase. [source:refseq;acc:nm\_012203]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8582.43\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8915.89\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.03885\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
954\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
adp-ribosylation factor-like protein 4. [source:swissprot;acc:p40617]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8212.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8531.84\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
casein kinase i, alpha isoform (ec 2.7.1.-) (cki-alpha) (ck1). [source:swissprot;acc:p48729]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4906.33\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5382.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09705\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
955\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
camp responsive element binding protein 3; luman; cyclic amp response element (cre)-binding protein/activating transcription factor 1; basic leucine zipper protein; transcription factor lzip-alpha. [source:refseq;acc:nm\_006368]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8212.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8531.84\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03885\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
uridine kinase-like 1. [source:swissprot;acc:q9nwz5]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5548.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6086.89\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09698\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
956\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dimethylaniline monooxygenase [n-oxide forming] 3 (ec 1.14.13.8) (hepatic flavin-containing monooxygenase 3) (fmo 3) (dimethylaniline oxidase 3) (fmo form 2) (fmo ii). [source:swissprot;acc:p31513]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5364.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5884.89\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09695\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
myeloblast kiaa0223 (fragment). [source:sptrembl;acc:q92619]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8628.43\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8963.59\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03884\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
957\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
nicotinate-nucleotide pyrophosphorylase [carboxylating] (ec 2.4.2.19) (quinolinate phosphoribosyltransferase [decarboxylating]) (qaprtase) (qprtase). [source:swissprot;acc:q15274]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
7895.83\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8202.18\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0388\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
structure-specific recognition protein 1 (ssrp1) (recombination signal sequence recognition protein) (t160) (chromatin-specific transcription elongation factor 80 kda subunit) (fact 80 kda subunit). [source:swissprot;acc:q08945]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4483.26\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4917.77\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09692\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
958\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cholinephosphate cytidylyltransferase b (ec 2.7.7.15) (phosphorylcholine transferase b) (ctp:phosphocholine cytidylyltransferase b) (ct b) (cct b) (cct-beta). [source:swissprot;acc:q9y5k3]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8059.35\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8371.9\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03878\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
chromatin-specific transcription elongation factor large subunit. [source:refseq;acc:nm\_007192]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4483.26\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4917.77\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09692\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
959\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cholinephosphate cytidylyltransferase a (ec 2.7.7.15) (phosphorylcholine transferase a) (ctp:phosphocholine cytidylyltransferase a) (ct a) (cct a) (cct-alpha). [source:swissprot;acc:p49585]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8059.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8371.83\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03875\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sh2 domain binding protein 1; tpr-containing, sh2-binding phosphoprotein. [source:refseq;acc:nm\_014633]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
4379.28\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4803.59\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09689\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
960\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein kinase c, epsilon type (ec 2.7.1.-) (npkc-epsilon). [source:swissprot;acc:q02156]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
11773\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10733.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09688\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
reticulon protein 2 (neuroendocrine-specific protein-like 1) (nsp-like protein 1) (nspli). [source:swissprot;acc:o75298]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8206.42\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8524.26\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03873\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
961\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
camp response element-binding protein cre-bpa. [source:refseq;acc:nm\_004904]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8484.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8813.34\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03872\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
peptidyl-prolyl cis-trans isomerase b precursor (ec 5.2.1.8) (ppiase) (rotamase) (cyclophilin b) (s-cyclophilin) (scylp) (cyp-s1). [source:swissprot;acc:p23284]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11773\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10733.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09688\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
962\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
e-1 enzyme. [source:refseq;acc:nm\_021204]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8312.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8634.21\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0387\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
udp-n-acetylglucosamine--peptide n-acetylglucosaminyltransferase 110 kda subunit (ec 2.4.1.-) (o-glcnac transferase p110 subunit). [source:swissprot;acc:o15294]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
11773\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
10733.2\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.09688\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
963\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytochrome c oxidase subunit iv isoform 1, mitochondrial precursor (ec 1.9.3.1) (cox iv-1) (cytochrome c oxidase polypeptide iv). [source:swissprot;acc:p13073]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
glycogenin-2 (ec 2.4.1.186) (gn-2) (gn2). [source:swissprot;acc:o15488]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8248.55\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8567.81\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0387\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/